Gilead Sciences Inc (XTER:GIS)
€ 114.1 -0.76 (-0.66%) Market Cap: 143.26 Bil Enterprise Value: 155.94 Bil PE Ratio: 17.90 PB Ratio: 6.94 GF Score: 82/100

Q1 2026 Gilead Sciences Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: €114.68
Operator

Good afternoon, everyone, and welcome to Gilead's first-quarter 2026 earnings conference call. My name is Rebecca, and I'll be today's host. (Operator Instructions)

Now, I'll hand the call over to Jacquie Ross, Senior Vice President, Treasurer, and Head of Investor Relations.

Jacquie Ross
Gilead Sciences Inc - Senior Vice President, Treasurer and Investor Relations

Thank you, Rebecca. Just our market close today, we issued a press release with earnings results for the first quarter of 2026. The press release, slides and supplementary data are available on the Investors section of our website at gilead.com.

The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial and Corporate Affairs Officer, Johanna Mercier; our Chief Medical Officer, Dietmar Berger; and our Chief Financial Officer, Andrew Dickinson. After that, we'll open the call to Q&A where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.

Let me remind you that we will be making

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot